Osteoarthritis is a common degenerative joint disease characterized by articular cartilage degeneration, subchondral bone sclerosis, and synovial inflammation. The superficial layer of articular cartilage serves as the first line of defense against osteoarthritis progression, with chondrocytes in this layer possessing unique biological functions and mechanical properties. The degenerative changes in osteoarthritis often begin with disturbances in superficial layer cells. The epidermal growth factor receptor (EGFR) has multiple biological functions, and its activation can promote cell growth, survival, adhesion, migration, and differentiation. Studies have shown that the EGFR pathway plays a crucial role in maintaining the homeostasis of superficial cartilage cells. Alexa Fluor 488-labeled EGF protein can be used to detect EGFR expression, distribution, and binding activity in cartilage tissues, providing a technical tool for studying this signaling pathway.
Researchers constructed a mouse model with cartilage-specific overexpression of HBEGF to investigate the effects of excessive activation of the EGFR signaling pathway in cartilage tissues. HBEGF is one of the key ligands of EGFR, and its overexpression can activate downstream EGFR signaling pathways. By crossing Col2-Cre and Aggrecan-CreER mice with Rosa-DTR mice, a cartilage-specific HBEGF-overexpressing mouse model was established. The results showed that HBEGF overexpression significantly thickened the growth plate and articular cartilage. Histological experiments also revealed an increased number of cartilage progenitor cells in the articular cartilage of these mice, along with slowed osteoarthritis progression. These findings suggest that moderate activation of the EGFR signaling pathway has protective effects on articular cartilage.
Intra-articular injection of gefitinib in HBEGF-overexpressing mice abolished the protective effects on articular cartilage, demonstrating that HBEGF's protective role in osteoarthritis is EGFR-dependent. In the DMM surgery-induced osteoarthritis model, cartilage degeneration was significantly reduced in HBEGF-overexpressing mice, with markedly lower Mankin scores. Nanoindentation tests showed superior mechanical properties of cartilage in HBEGF-overexpressing mice. Immunohistochemical results indicated enhanced anabolism and reduced catabolism in cartilage tissues of these mice. These results suggest that targeted activation of the EGFR signaling pathway in cartilage can effectively delay osteoarthritis progression. Alexa Fluor 488-labeled EGF protein can be used to detect EGFR activation status under different conditions, providing quantitative analysis for mechanistic studies.
To achieve targeted activation of the EGFR signaling pathway, researchers developed stable nanoparticles and coupled them with TGFα, an EGFR ligand, to create novel nanocomplexes. These complexes retained TGFα's bioactivity, remained stable in vivo, and effectively delivered TGFα into cells. Dynamic light scattering measurements confirmed uniform particle size distribution, while transmission electron microscopy revealed spherical morphology. Zeta potential measurements indicated excellent dispersibility. Cell viability assays confirmed the nanocomplexes' non-toxicity to chondrocytes. Western blotting showed that TGFα nanoparticles effectively activated downstream EGFR signaling in chondrocytes, evidenced by elevated ERK phosphorylation levels. Confocal imaging demonstrated efficient uptake of fluorescently labeled nanoparticles by chondrocytes. Alexa Fluor 488-labeled EGF protein served as a positive control to validate the bioactivity of TGFα nanoparticles.
In vitro studies demonstrated that TGFα nanoparticles exhibit excellent cartilage absorption, penetration, and joint retention capabilities. Using a bovine articular cartilage model with thickness comparable to human cartilage, confocal imaging showed TGFα nanoparticles could penetrate the full cartilage layer, with penetration depth increasing over incubation time. Quantitative analysis revealed nanoparticles reached deep cartilage layers after 6 days of incubation. Following intra-articular injection, immunofluorescence imaging of mouse knee joints showed predominant nanoparticle distribution in cartilage tissues, with prolonged fluorescence signals. In vivo imaging confirmed significantly longer joint retention times for nanoparticles compared to free ligands. These properties make TGFα nanoparticles an ideal intra-articular drug delivery system. Alexa Fluor 488-labeled EGF protein can be used to compare cartilage penetration capacities of different ligands, providing optimization insights for nano-delivery systems.
Using the DMM mouse model, researchers investigated the therapeutic effects of TGFα nanoparticles on osteoarthritis progression. Compared to controls, intra-articular injection of TGFα nanoparticles significantly reduced post-DMM Mankin scores and increased non-calcified cartilage thickness. Early-stage osteoarthritis models also showed cartilage protection effects. Immunohistochemistry revealed that TGFα nanoparticle treatment reversed DMM-induced cartilage metabolic disorders, promoting anabolic marker expression while suppressing catabolic markers. Micro-CT scans demonstrated reduced subchondral bone sclerosis. Histological analysis indicated alleviated synovial inflammation. Von Frey behavioral tests suggested TGFα nanoparticle treatment mitigated joint pain in osteoarthritic mice.
Nanjing UA-Bio Technology Co., Ltd. has independently developed "Alexa Fluor 488-Labeled EGF Protein, Human" (Catalog No.: UA011307), a high-performance fluorescent-labeled probe specifically designed for EGFR signaling pathway tracking and live-cell imaging. This human epidermal growth factor (EGF) is labeled with Alexa Fluor 488, efficiently binding to EGFR receptors and activating downstream signaling pathways. It serves as a stable and reliable standardized tool for receptor-ligand interaction studies, endocytosis tracking, and drug screening.
| Core Product Advantages | Detailed Parameters / Functional Description |
|---|---|
| High Purity and Intact Bioactivity | The product utilizes an internationally advanced recombinant expression system and highly standardized purification processes, validated through multi-dimensional quality control to ensure >95% purity and correct native conformation. The Alexa Fluor 488 labeling process is optimized to maintain high labeling efficiency while preserving EGF's high-affinity binding to EGFR receptors and receptor activation functions, accurately simulating physiological EGF-mediated cell proliferation, migration, and internalization processes.-- |
| High Brightness and Excellent Photostability | Labeled with Alexa Fluor 488 fluorescent dye, which exhibits extremely high fluorescence brightness, excellent photostability, and wide pH tolerance (pH 4-10). Under 488 nm excitation, it emits bright green fluorescence signals, suitable for long-term live-cell dynamic imaging and high-resolution confocal microscopy.-- |
| Exceptional Batch-to-Batch Consistency and Stability | Strict management from protein expression, labeling to purification quality control, combined with a comprehensive release testing system, ensures each batch of products maintains stable binding activity, consistent fluorescence intensity, and excellent long-term stability. This provides reliable quality assurance for continuous EGFR signaling pathway research.-- |
| Complete Solutions and Professional Support | We provide thoroughly validated standard experimental protocols, typical imaging data, and detailed result interpretation guides to help establish stable and reproducible live-cell imaging workflows. Nanjing UA-Bio's technical team offers comprehensive professional consultation and support for research design, experimental optimization, and data analysis.-- |
Nanjing UA-Bio Technology Co., Ltd. is committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding "Alexa Fluor 488-Labeled EGF Protein, Human" (Catalog No.: UA011307), please feel free to contact us.
